Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy

Author： Yothaisong Supak   Dokduang Hasaya   Techasen Anchalee   Namwat Nisana   Yongvanit Puangrat   Bhudhisawasdi Vajarabhongsa   Puapairoj Anucha   Riggins Gregory   Loilome Watcharin  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.34, Iss.6, 2013-12, pp. : 3637-3648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

2.1.3. Pan-PI3K/mTOR Inhibition

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 77-76

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway

By          

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 212-218

Spandidos Publications

Access to resources Recommend Favorite

Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 9, 2009-11 ,pp. : 1024-1038

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Inhibition of PI3K/Akt/mTOR Signaling by Natural Products)

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 967-970

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 10, 2013-12 ,pp. : 1552-1564

Bentham Science Publishers

Access to resources Recommend Favorite